News
Awards. DEI Awards; Innovation Awards; Resources. Webinars; Fierce Events; Industry Events; Podcasts; Survey ...
A nuclear stress test shows how well a person's blood flows to the heart during rest and activity. Learn more about the benefits and what to expect with a nuclear stress test.
Lexiscan approved for MPI testing Lexiscan (regadenoson injection, from Astellas), a pharmacologic stress agent, is now available for use in radionuclide myocardial perfusion imaging (MPI) for ...
Astellas Pharma US, Inc. today announced the commercial availability of Lexiscan(TM) (regadenoson) injection, an A2A adenosine receptor agonist, for use as a pharmacologic stress ...
Pharmacological stress testing can be done using either regadenoson (Lexiscan, Astellas) or dobutamine. The use of persantine and adenosine is much less common.
Lexiscan is the first A2A adenosine receptor agonist shown to be safe and effective as a pharmacologic stress agent in MPI studies. Lexiscan is delivered as a rapid bolus (approximately 10 seconds ...
Regadenoson injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress. Dr. Reddy's is offering ...
The cardiac nuclear stress test agents Lexiscan, or regadenoson, and Adenoscan, or adenosine, are FDA approved for use during cardiac stress tests in patients who cannot exercise adequately.
It looks like Astellas has been unsuccessful in its attempt to block Pfizer's generic medicines unit Hospira from launching a copycat version of big-selling pharmacologic stress agent Lexiscan in ...
Astellas has won a reprieve in its attempt to stop Pfizer's generic medicines unit Hospira launching a copycat version of its pharmacologic stress agent Lexiscan in the US – but only for a ...
The U.S. Food and Drug Administration has issued a warning that there is a rare but serious risk of heart attack or death associated with the use of cardiac nuclear stress test agents Lexiscan ...
Lexiscan is an A2A adenosine receptor agonist approved for use as a pharmacologic stress agent in radionuclide MPI studies in patients unable to undergo adequate exercise stress.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results